Aggregator Trap: Why Diagnostic Labs Are Losing 40% of Their Walk-Ins to Portals And the AEO Playbook to Win Them Back

Listing on PharmEasy, Tata 1mg and Practo feels like distribution. It is actually displacement. Here is how to tell the difference and what to do about it.

Let's start with a number that most diagnostic lab owners don't want to look at directly. When a patient books a thyroid panel through Tata 1mg or PharmEasy, the lab gets the sample, the lab does the work and the lab delivers the report.

Then the aggregator takes between 20 and 40% of the transaction value in commissions, discounts and price compression, every single time.

Multiply that across your monthly walk-in volume. Now ask yourself, "How much of the revenue that should be yours is currently sitting in someone else's P&L?"

This is the aggregator trap and it is more precisely designed than most labs realise.

The Architecture of the Trap

Here is how it works.

The patient goes to Google and types, "HbA1c test near me". In 2021, your lab might have appeared in the top results, however in 2026, the top three to four positions are almost entirely occupied by PharmEasy, Tata 1mg, Practo and Healthians, all offering the same test at discounts of 30 to 70% off the market rate (Univest, May 2026).

Your lab appears further down. The patient clicks the aggregator and the aggregator routes the booking back to your lab anyway because the aggregator doesn't have a lab. It has your lab, wearing their uniform.

Here is the punchline. The patient now thinks of Tata 1mg as their diagnostic provider, not you. You have spent money on your equipment, your technicians, your quality certifications, your NABL accreditation, etc. and the aggregator has captured the brand relationship with zero clinical investment.

When that patient needs a test next month, she doesn't search for your lab. She opens the 1mg app. You have trained your own patients to come to you through someone else.

Why This Problem Is About to Get Significantly Worse

In 2024 and 2025, the aggregator threat was primarily a pricing and a visibility problem. In 2026, it has become an AI search problem as well.

When a patient asks Google AI Overview, "Which diagnostic lab should I use for a full body checkup" or asks ChatGPT, "What is the best lab for diabetes testing in Bangalore", the AI engine cites the sources it trusts most. Those sources are overwhelmingly aggregators and large chains with structured, content-rich websites.

The independent lab with a five-page website and a Google Maps listing doesn't exist in AI search, it doesn't exist in the citations and increasingly, it won't exist in the patient's awareness until after they've already booked elsewhere.

India's diagnostic labs market stood at $10.95 billion in 2025 and is projected to reach $28.53 billion by 2034, growing at a CAGR of 11.23%. The volume of tests is growing. The question is not whether there are enough patients, rather who they book-through when they go looking. 

The AEO Playbook: How Independent Labs Win on AI Search

The aggregator advantage is real but it is specific. Aggregators dominate generic, undifferentiated queries like "Cheapest HbA1c test near me" or "Full body checkup discount",etc. These are price-driven searches and the aggregator will almost always win them.

But there is an entire category of search which is high-intent, high-trust and clinically specific where the aggregator has no structural advantage at all.

"What does an HbA1c of 7.2 mean for a Type 2 diabetic?", a clinical question the aggregator cannot answer. A lab that builds a detailed, doctor-reviewed explainer around this query owns it. Every person who finds that page is a high-intent patient who will trust the lab that gave them clarity.

"Which lab in Lucknow is best for thyroid panel testing?", a comparison query. The aggregator shows all labs equally. The lab that has published a methodology explainer on why it's analyser produces more accurate TSH readings, what it's QC protocols are earns trust before the patient even books.

"How to prepare for a lipid profile test?", a query by a patient about to book. The lab that answers this question and links the answer to its own online booking intercepts the patient at the highest-intent moment.

"Home blood collection service in Kolkata". The aggregator ranks nationally. A lab with specific neighbourhood-level content can outrank it on hyper-local queries it's national SEO structure isn't set-up to win.

What We Build: The Test-by-Test Content Architecture

Most diagnostic lab websites have one page called "Our tests", a long list of test names. Menus don't rank, they don't get cited by AI engines and menus definitely don't build trust.

What we build instead is a test-by-test content architecture. Each significant test gets its own landing page, a full clinical explainer covering what the test measures, why a doctor might order it, what normal and abnormal ranges mean, how to prepare, how to interpret the result and how it connects to the next diagnostic step.

These pages rank organically for test-name queries aggregators don't bother creating content for. The lab get cited by AI engines when patients ask clinical questions about those tests and the lab creates a trust signal ensuring that it understands diagnostics at a clinical level that no aggregator can replicate.

BattiLynk AI builds each test-specific page in the lab's clinical voice, referenced against the clinical standards the lab actually uses. It auto-generates the internal link structure: 

Test page → Related test cluster → Preventive health package → Home collection booking.

BattiSense builds the FAQ schema and JSON-LD markup that converts those pages into AI citations. When a patient asks Google AI Overview, "What is the normal TSH range for women over 40?", the lab that has a properly structured, clearly attributed clinical answer gets cited. That citation comes with a name, a brand and a direct link to book not a comparison platform.

A possible 'Home-Collection Booking Agent' closes the conversion. Patient lands on the lab's page through a specific test query. The agent identifies the test from the page context, confirms location and preferred slot, sends collection preparation instructions and follows-up with the report notification. The aggregator's entire convenience advantage is replicated on the lab's own platform, without paying 20–40% for the privilege.

The Three Mistakes That Keep Labs Trapped

One: Listing on aggregators without tracking what it costs you in brand equity. Every booking that comes through an aggregator is a booking that didn't learn your lab's name. Track your aggregator dependency ratio. What percentage of your monthly bookings come through third-party platforms and if it is above 30%, you are building someone else's brand.

Two: Competing on the aggregator's terms. If your strategy is, "We are 10% cheaper than the aggregator's price", you have already lost. The aggregator can subsidise discounts indefinitely whereas you cannot. The only winning strategy is to compete on dimensions the aggregator cannot reach such as clinical authority, local trust, AEO-structured content and specific patient relationships.

Three: Ignoring the AI search channel because you can't see it in Google Analytics. AI-generated answers don't always produce trackable clicks but they shape patient-decisions. The patient who asked ChatGPT, "What's the best lab for HbA1c in Pune" and got your lab's name in the response is already predisposed to choose you before they open Google. This influence is invisible in most dashboards but is real and is growing every month.

India's diagnostic labs market is growing at 11.23% annually. The patients are there. The question is whether they find you through an aggregator that takes a third of your revenue or through your own content that costs you nothing per booking after it's built.

This mind-set shift alone changes everything💡.

About the Author: This article was written by Boudhhayan Duttaa, Founder at Batti Jalao — India's AI-led healthcare marketing agency. We specialise in patient acquisition, GEO, AEO and AI-powered marketing for diagnostic labs, hospitals and healthtech brands.